These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 6970630

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of acute lymphoblastic leukemia with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Mitchell BS, Koller CA, Kelley WN.
    Adv Exp Med Biol; 1979; 122B():347-50. PubMed ID: 317568
    [No Abstract] [Full Text] [Related]

  • 3. Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia.
    Prentice HG, Smyth JF, Ganeshaguru K, Wonke B, Bradstock KF, Janossy G, Goldstone AH, Hoffbrand AV.
    Lancet; 1980 Jul 26; 2(8187):170-2. PubMed ID: 6105339
    [Abstract] [Full Text] [Related]

  • 4. Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycin.
    Cummings FJ, Crabtree GW, Wiemann MC, Spremulli EN, Parks RE, Calabresi P.
    Clin Pharmacol Ther; 1988 Nov 26; 44(5):501-9. PubMed ID: 3263248
    [Abstract] [Full Text] [Related]

  • 5. Clinical pharmacology of deoxycoformycin.
    Major PP, Agarwal RP, Kufe DW.
    Blood; 1981 Jul 26; 58(1):91-6. PubMed ID: 6263381
    [Abstract] [Full Text] [Related]

  • 6. Low-dose deoxycoformycin in lymphoid malignancy.
    Grever MR, Leiby JM, Kraut EH, Wilson HE, Neidhart JA, Wall RL, Balcerzak SP.
    J Clin Oncol; 1985 Sep 26; 3(9):1196-201. PubMed ID: 2993534
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B.
    Dillman RO, Mick R, McIntyre OR.
    J Clin Oncol; 1989 Apr 26; 7(4):433-8. PubMed ID: 2784491
    [Abstract] [Full Text] [Related]

  • 9. Purinogenic lymphocytotoxicity: clues to a wider chemotherapeutic potential for the adenosine deaminase inhibitors.
    Kefford RF, Fox RM.
    Cancer Chemother Pharmacol; 1983 Apr 26; 10(2):73-8. PubMed ID: 6600985
    [No Abstract] [Full Text] [Related]

  • 10. Clinical consequences of 2'-deoxycoformycin treatment in patients with refractory adult T-cell leukaemia.
    Yamaguchi K, Yul LS, Oda T, Maeda Y, Ishii M, Fujita K, Kagiyama S, Nagai K, Suzuki H, Takatsuki K.
    Leuk Res; 1986 Apr 26; 10(8):989-93. PubMed ID: 3489140
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Therapeutic selectivity of and predication of response to 2'-deoxycoformycin in acute leukaemia.
    Prentice HG, Russell NH, Lee N, Ganeshaguru K, Blacklock H, Piga A, Smyth JF, Hoffbrand AV.
    Lancet; 1981 Dec 05; 2(8258):1250-4. PubMed ID: 6118669
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes.
    Kefford RF, Fox RM.
    Br J Haematol; 1982 Apr 05; 50(4):627-36. PubMed ID: 6978147
    [Abstract] [Full Text] [Related]

  • 19. Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Hershfield MS, Kurtzberg J, Harden E, Moore JO, Whang-Peng J, Haynes BF.
    Proc Natl Acad Sci U S A; 1984 Jan 05; 81(1):253-7. PubMed ID: 6607471
    [Abstract] [Full Text] [Related]

  • 20. Deoxycoformycin in the treatment of leukemias and lymphomas.
    Smyth JF, Prentice HG, Proctor S, Hoffbrand AV.
    Ann N Y Acad Sci; 1985 Jan 05; 451():123-8. PubMed ID: 3878113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.